CRF Health Selected to Support Large Recorded COPD Trial


CRF Health's TrialMax platform has been selected to support a large Phase III study in COPD. The platform will be used to improve efficiency and increase patient-reported outcomes compliance for its 19,000 clinical trial patients.   Read the full release here


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.